FIND SERVICES

SATuRN output: reports, clinical cases & publications

Here we provide you with HIV & TB drug resistance information in the form of reports, clinical cases, tweets and publications.
In this new section of the bioafrica.net website, physicians, researchers and public health officials can learn about our drug resistance work and its application to the management of patients failing ARVs and anti-TB therapies.

Reports


SATuRN Collaborates on a Successful Molecular Diagnostics in HIV/AIDS and Tuberculosis in Zimbabwe, 6-9 Aug 2013

By Justen Manasa - 2013-08-21
SATuRN 2013 report


SATuRN and Khethimpilo HIV Drug Resistance and Clinical Management Workshop Report, Durban, 11-12 July 2013

By Dean Solomon and Tulio de Oliveira - 2013-08-01
SATuRN 2013 report


Major data analysis determines the trends of HIV-1 drug resistance mutations in South Africa.

By Tulio de Oliveira - 2013-07-01
SATuRN report 2013


Transferring knowledge and skills to frontline medical personnel fighting the HIV & TB epidemics in rural South Africa

By Tulio de Oliveira, Justen Manasa, Richard Lessells - 2013-03-16
SATuRN 2013 report


Bioafrica.net & SATuRN webpages received 186,746 visits in the past 12 months!

By Tulio de Oliveira - 2013-02-26
SATuRN 2013 report


Clinical Case Study: The Diagnosis and Management of First-line Antiretroviral Treatment Failure

By Theresa Rossouw, Tulio de Oliveira & Richard Lessells - 2013-01-16
SATuRN 2012 report


2nd Nurses and Health Care Workers Drug Resistance Training for the scale-up of resistance testing in the Free State Province, South Africa

By Dominique Goedhals & Cloete van Vuuren - 2012-07-10
SATuRN 2012 report

SATuRN output, 15 minutes, All reports...

Clinical Cases

HIV Case 1 - Adult female with virological failure on first line d4T/3TC/EFV
HIV Case 2 - Adult female patient with virological failure on first line therapy after substitution of EFV to NVP
HIV Case 3 - Adult female patient on treatment for epilepsy with virological failure on TDF/3TC/EFV; previous single dose NVP for PMTCT
HIV Case 4 - Adult female patient with virological and immunological failure after treatment interruption for symptomatic hyperlactataemia
HIV Case 5 - Adolescent initiated on first line therapy of d4T/3TC/EFV with virological and immunological failure
HIV Case 6 - Adult male patient with adverse effects and multiple ARV treatment switches. No virological response to LPV/r based second line therapy
HIV Case 7 - Adolescent case with adherence and toxicity problems
HIV Case 8 - Adult patient initiated on first line d4T/3TC/EFV with low CD4+ cell count (34 cells/ul) and concurrent TB treatment

Publications

Chikungunya virus. Nature Ecology & Evolution (2026), I.F.:0

Re-emergence of DENV-3 in Paraguay After Two Decades: A Genomic and Epidemiological Investigation. Emerging Microbes & Infections (2026), I.F.:0

Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny. Nature Methods (2026), I.F.:0

Ancient Pathogen Genomics in Africa – Current Evidence and Future Directions. Preprints.org (2026), I.F.:0

CholeraSeq: a comprehensive genomic pipeline for cholera surveillance and near real-time outbreak investigation. Bioinformatics (2026), I.F.:0

Enhancing SARS-CoV-2 response capacity in Africa and other centers for research in emerging infectious diseases centres through a collaborative training programme. Clinical Microbiology and Infection (2026), I.F.:0

Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalition. International Journal of Infectious Diseases (2026), I.F.:0

Spatiotemporal patterns of Rift Valley fever virus in Africa: a retrospective genomic epidemiology and phylodynamic modelling study. The Lancet Microbe (2026), I.F.:0

Cross-platform protocol for HTLV-1 whole-genome sequencing using nanopore and Illumina technologies. Next Research (2026), I.F.:0

Faecal Coliforms and Escherichia coli Contamination in Drinking Water Sources in Cholera Hotspot Areas of Lusaka District, Zambia: A Cross-Sectional Study. Microorganisms (2026), I.F.:0

SATuRN output,15 minutes, All publications...

KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).


Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira